• Biologie

  • Oncogènes et suppresseurs de tumeurs

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

Cet article passe en revue les travaux récents sur le rôle des récepteurs PPAR (récepteurs activés par les proliférateurs de peroxysomes, régulant notamment l'homéostasie glucidique et lipidique) dans la carcinogenèse et évalue la possibilité de mettre ces connaissances à profit pour la chimioprévention des cancers

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.

http://dx.doi.org/10.1038/nrc3214

Voir le bulletin